Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

Detalles Bibliográficos
Autores principales: Chew, Kara W., Moser, Carlee, Daar, Eric S., Wohl, David A., Li, Jonathan Z., Coombs, Robert W., Ritz, Justin, Giganti, Mark, Javan, Arzhang Cyrus, Li, Yijia, Choudhary, Manish C., Deo, Rinki, Malvestutto, Carlos, Klekotka, Paul, Price, Karen, Nirula, Ajay, Fischer, William, Bala, Veenu, Ribeiro, Ruy M., Perelson, Alan S., Fletcher, Courtney V., Eron, Joseph J., Currier, Judith S., Hughes, Michael D., Smith, Davey M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Publisher Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851732/
https://www.ncbi.nlm.nih.gov/pubmed/36658128
http://dx.doi.org/10.1038/s41467-023-35835-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851732/
https://www.ncbi.nlm.nih.gov/pubmed/36658128
http://dx.doi.org/10.1038/s41467-023-35835-3

Ejemplares similares